Evaluation of ERIC-PCR and MALDI-TOF as typing tools for multidrug resistant Klebsiella pneumoniae clinical isolates from a tertiary care center in India.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
07
2022
accepted:
01
11
2022
entrez:
17
11
2022
pubmed:
18
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
Multidrug resistant Klebsiella pneumoniae is associated with nosocomial infections in both outbreak and non-outbreak situations. The study intends to evaluate the potential of enterobacterial repetitive intergenic consensus- polymerase chain reaction (ERIC-PCR), a genomic based typing and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) proteomic-based typing techniques for clonal relatedness among multidrug resistant Klebsiella pneumoniae isolates. Multidrug resistant clinical isolates of Klebsiella pneumoniae (n = 137) were collected from March 2019 to February 2020. Identification and protein-based phylogenetic analysis were performed by MALDI-TOF MS. Genomic typing was done by ERIC-PCR and analyzed by an online data analysis service (PyElph). Dice method with unweighted pair group method with arithmetic mean (UPGMA) program was used to compare the ERIC profiles. The samples were also evaluated by PCR for the presence of genes encoding carbapenemases, extended spectrum beta lactamases (ESBLs) and mobile colistin resistance-1 (mcr1). The study presents ERIC-PCR as more robust and better discriminatory typing tool in comparison to MALDI-TOF for clonal relatedness in multidrug resistant K. pneumoniae clinical isolates. Isolates were typed into 40 ERIC types, and six groups by MALDI-TOF-MS. PCR-based analysis revealed that all the strains harbored two or more ESBL and carbapenemase genes. None of the isolates revealed the presence of the plasmid mediated mcr-1 gene for colistin resistance.
Sections du résumé
BACKGROUND AND AIM
Multidrug resistant Klebsiella pneumoniae is associated with nosocomial infections in both outbreak and non-outbreak situations. The study intends to evaluate the potential of enterobacterial repetitive intergenic consensus- polymerase chain reaction (ERIC-PCR), a genomic based typing and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) proteomic-based typing techniques for clonal relatedness among multidrug resistant Klebsiella pneumoniae isolates.
METHODOLOGY
Multidrug resistant clinical isolates of Klebsiella pneumoniae (n = 137) were collected from March 2019 to February 2020. Identification and protein-based phylogenetic analysis were performed by MALDI-TOF MS. Genomic typing was done by ERIC-PCR and analyzed by an online data analysis service (PyElph). Dice method with unweighted pair group method with arithmetic mean (UPGMA) program was used to compare the ERIC profiles. The samples were also evaluated by PCR for the presence of genes encoding carbapenemases, extended spectrum beta lactamases (ESBLs) and mobile colistin resistance-1 (mcr1).
RESULT AND CONCLUSION
The study presents ERIC-PCR as more robust and better discriminatory typing tool in comparison to MALDI-TOF for clonal relatedness in multidrug resistant K. pneumoniae clinical isolates. Isolates were typed into 40 ERIC types, and six groups by MALDI-TOF-MS. PCR-based analysis revealed that all the strains harbored two or more ESBL and carbapenemase genes. None of the isolates revealed the presence of the plasmid mediated mcr-1 gene for colistin resistance.
Identifiants
pubmed: 36395172
doi: 10.1371/journal.pone.0271652
pii: PONE-D-22-18906
pmc: PMC9671336
doi:
Substances chimiques
Colistin
Z67X93HJG1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271652Informations de copyright
Copyright: © 2022 Kundu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Rev Soc Bras Med Trop. 2012 Oct;45(5):572-8
pubmed: 23152339
Clin Infect Dis. 2013 Aug;57(4):564-72
pubmed: 23595835
PLoS One. 2014 Jun 27;9(6):e101212
pubmed: 24971598
Nucleic Acids Res. 1991 Dec 25;19(24):6823-31
pubmed: 1762913
Int J Gen Med. 2019 Nov 28;12:437-446
pubmed: 31819594
Antimicrob Agents Chemother. 2008 Mar;52(3):813-21
pubmed: 18070961
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S225-S230
pubmed: 30423052
Microb Drug Resist. 2014 Feb;20(1):45-51
pubmed: 23692050
Nat Rev Microbiol. 2010 Jan;8(1):74-82
pubmed: 20010952
Int J Med Microbiol. 2020 Jan;310(1):151357
pubmed: 31570247
Infect Drug Resist. 2021 Mar 17;14:1019-1035
pubmed: 33762830
J Clin Microbiol. 2004 Sep;42(9):4242-9
pubmed: 15365018
J Antimicrob Chemother. 2010 Mar;65(3):490-5
pubmed: 20071363
Indian J Med Microbiol. 2017 Jul-Sep;35(3):361-368
pubmed: 29063880
Biomed Res Int. 2015;2015:535027
pubmed: 26101775
Proteomics. 2002 Jun;2(6):747-53
pubmed: 12112858
FEMS Microbiol Rev. 2017 May 1;41(3):252-275
pubmed: 28521338
BMC Bioinformatics. 2012 Jan 13;13:9
pubmed: 22244131
J Clin Microbiol. 2005 Aug;43(8):4178-82
pubmed: 16081970
Am J Trop Med Hyg. 2012 Jun;86(6):1018-25
pubmed: 22665611
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
J Microbiol Methods. 2013 Sep;94(3):390-6
pubmed: 23916798
Antibiotics (Basel). 2020 Aug 13;9(8):
pubmed: 32823707
Einstein (Sao Paulo). 2019 May 16;17(4):eGS4444
pubmed: 31116310
Sci Rep. 2016 Dec 22;6:38929
pubmed: 28004732
Antimicrob Resist Infect Control. 2020 Jan 3;9(1):5
pubmed: 31911833
J Clin Microbiol. 1988 Nov;26(11):2465-6
pubmed: 3069867
Microb Drug Resist. 2017 Jun;23(4):480-487
pubmed: 27575913
Diagn Microbiol Infect Dis. 2014 Dec;80(4):267-71
pubmed: 25266674
Eur J Pediatr. 2020 Dec;179(12):1843-1849
pubmed: 32524198
Am J Infect Control. 2016 Nov 1;44(11):1374-1380
pubmed: 27156198
J Hosp Infect. 2018 Dec;100(4):e253-e256
pubmed: 29605188